| |
| |
|
| Insider
Information: |
Nisi Rudolph |
| Relationship: |
Director |
| City: |
Bala Cynwyd |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
124,836 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$51,931 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
124,836 |
|
|
| Total
Value |
$51,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cordex Pharma Inc |
CDXP |
Director |
2004-08-30 |
81,918 |
|
0 |
Premium* |
|
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2017-10-10 |
42,918 |
2009-10-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2017-10-10 |
4 |
A |
$0.38 |
$6,509 |
D/D |
17,130 |
42,918 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2017-07-06 |
4 |
A |
$0.59 |
$6,445 |
D/D |
10,924 |
25,788 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2017-06-20 |
4 |
S |
$0.55 |
$273 |
D/D |
(500) |
14,864 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2017-04-10 |
4 |
A |
$0.59 |
$6,447 |
D/D |
10,927 |
15,364 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2017-01-20 |
4 |
A |
$1.98 |
$6,459 |
D/D |
3,262 |
4,437 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2014-02-07 |
4 |
B |
$4.94 |
$98,742 |
D/D |
20,000 |
23,500 |
2.39 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2014-01-29 |
4 |
S |
$5.28 |
$1,320,000 |
D/D |
(250,000) |
3,500 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2014-01-29 |
4 |
OE |
$0.72 |
$355,000 |
D/D |
250,000 |
253,500 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2014-01-17 |
4 |
S |
$6.90 |
$1,380,000 |
D/D |
(200,000) |
3,500 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2014-01-15 |
4 |
OE |
$0.85 |
$203,000 |
D/D |
200,000 |
203,500 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2009-10-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
3,500 |
0 |
- |
|
| CDXP |
Cordex Pharma Inc |
Director |
– • – |
2004-08-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
81,918 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
